Global DTx reimbursement explorer

attexis - digitale Therapie bei ADHS im Erwachsenenalter is a digital therapeutic (DTx), developed by GAIA AG, used for ADHD (adults). It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA §139e SGB V; manufacturer price EUR599.40/90-day Rx (diga.bfarm.de).

Axia - für axiale Spondyloarthritis (axSpA) is a digital therapeutic (DTx), developed by Applimeda GmbH, used for axial spondyloarthritis. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR599.00/90-day Rx (diga-verzeichnis.de).

Cara Care für Reizdarm is a digital therapeutic (DTx), developed by HiDoc Technologies GmbH, used for irritable bowel syndrome. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR248.00/90-day Rx (diga-verzeichnis.de).

companion patella powered by medi is a digital therapeutic (DTx), developed by medi GmbH & Co. KG, used for patellar conditions / knee pain. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR223.49/90-day Rx (diga.bfarm.de).

companion(R) shoulder is a digital therapeutic (DTx), developed by medi GmbH & Co. KG, used for shoulder lesions/pain. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA (provisional); manufacturer price EUR419.00/90-day Rx (diga.bfarm.de).

deprexis is a digital therapeutic (DTx), developed by GAIA AG, used for depression. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR228.00/90-day Rx (diga.bfarm.de).

eCovery - Therapie bei Schmerzen im unteren Rücken is a digital therapeutic (DTx), developed by eCovery GmbH, used for lower back pain. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA (provisional); manufacturer price EUR574.00/90-day Rx (diga-verzeichnis.de).

edupression.com is a digital therapeutic (DTx), developed by edupression GmbH, used for depression. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR224.80/90-day Rx (diga.bfarm.de).

elevida is a digital therapeutic (DTx), developed by GAIA AG, used for multiple sclerosis (fatigue/mental health support). It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR243.00/90-day Rx (diga.bfarm.de).

elona explore - für die mentale Gesundheit is a digital therapeutic (DTx), developed by Elona Health GmbH, used for depression. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA (provisional); manufacturer price EUR535.49/90-day Rx (diga-verzeichnis.de).

elona therapy Depression is a digital therapeutic (DTx), developed by Elona Health GmbH, used for depression. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR229.50/90-day Rx (diga.bfarm.de).

Endo-App is a digital therapeutic (DTx), developed by Endo Health GmbH, used for endometriosis. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR235.80/90-day Rx (diga.bfarm.de).

glucura Diabetestherapie is a digital therapeutic (DTx), developed by Perfood GmbH, used for type 2 diabetes. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR499.80/90-day Rx (diga.bfarm.de).

HelloBetter Chronische Schmerzen is a digital therapeutic (DTx), developed by HelloBetter GmbH (GET.ON Institut), used for chronic pain. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR235.00/90-day Rx (diga.bfarm.de).

HelloBetter Diabetes is a digital therapeutic (DTx), developed by HelloBetter GmbH (GET.ON Institut), used for type 2 diabetes (psych. Comorbidity). It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR222.99/90-day Rx (diga.bfarm.de).

HelloBetter Panik is a digital therapeutic (DTx), developed by HelloBetter GmbH (GET.ON Institut), used for panic disorder. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR230.00/90-day Rx (diga.bfarm.de).

HelloBetter Schlafen is a digital therapeutic (DTx), developed by HelloBetter GmbH (GET.ON Institut), used for insomnia. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR241.25/90-day Rx (diga.bfarm.de).

HelloBetter Stress und Burnout is a digital therapeutic (DTx), developed by HelloBetter GmbH (GET.ON Institut), used for stress & burnout. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR235.00/90-day Rx (diga.bfarm.de).

HelloBetter Vaginismus Plus is a digital therapeutic (DTx), developed by HelloBetter GmbH (GET.ON Institut), used for vaginismus. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR235.00/90-day Rx (diga.bfarm.de).

hiToco(R): ADHS Elterntraining is a digital therapeutic (DTx), developed by Medigital GmbH (MEDICE Health Family), used for ADHD (parent training, children). It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA (provisional); manufacturer price EUR479.20/90-day Rx (diga.bfarm.de).

INKA is a digital therapeutic (DTx), developed by nextec medical GmbH, used for urinary incontinence. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA (provisional); manufacturer price EUR670.49/90-day Rx (diga.bfarm.de).

Invirto - Die Therapie gegen Angst is a digital therapeutic (DTx), developed by Sympatient GmbH, used for anxiety disorder. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR220.00/90-day Rx (diga.bfarm.de).

Kaia Rückenschmerzen is a digital therapeutic (DTx), developed by Kaia Health Software GmbH, used for back pain. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR221.49/90-day Rx (diga-verzeichnis.de).

Kalmeda is a digital therapeutic (DTx), developed by Pohl-Boskamp Digital Health GmbH, used for chronic tinnitus. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR189.00/90-day Rx (diga.bfarm.de).

Kranus Edera is a digital therapeutic (DTx), developed by Kranus Health GmbH, used for erectile dysfunction. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR235.00/90-day Rx (diga.bfarm.de).

Kranus Lutera is a digital therapeutic (DTx), developed by Kranus Health GmbH, used for prostate enlargement / urinary urgency. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR240.50/90-day Rx (diga.bfarm.de).

Kranus Mictera is a digital therapeutic (DTx), developed by Kranus Health GmbH, used for urinary incontinence. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR681.30/90-day Rx (diga.bfarm.de).

levidex is a digital therapeutic (DTx), developed by GAIA AG, used for multiple sclerosis (mental health support). It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR247.81/90-day Rx (diga.bfarm.de).

Mawendo is a digital therapeutic (DTx), developed by Mawendo GmbH, used for patellar conditions / knee pain. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA (one-off licence); manufacturer price EUR119.00 one-off licence (diga.bfarm.de).

Meine Tinnitus App is a digital therapeutic (DTx), developed by BAYOOCARE GmbH and operated by InfectoPharm Digital Health GmbH (Hamburg), used for tinnitus counselling. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA (one-off licence); manufacturer price EUR260.00 one-off licence (diga.bfarm.de).

memodio is a digital therapeutic (DTx), developed by memodio GmbH, used for dementia (early stage). It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA (provisional); manufacturer price EUR595.00/90-day Rx (diga.bfarm.de).

Mindable: Panik & Agoraphobie is a digital therapeutic (DTx), developed by Mindable Health GmbH, used for panic disorder / agoraphobia. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR245.50/90-day Rx (diga.bfarm.de).

Mindable: Soziale Phobie is a digital therapeutic (DTx), developed by Mindable Health GmbH, used for social phobia. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR765.00/90-day Rx (diga.bfarm.de).

My7steps App is a digital therapeutic (DTx), developed by My7steps gGmbH, used for depression. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR207.00/60-day Rx (diga.bfarm.de).

neolexon Aphasie is a digital therapeutic (DTx), developed by neolexon GmbH (formerly Limedix GmbH), used for aphasia (post-stroke). It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR223.01/90-day Rx (diga.bfarm.de).

NeuroNation MED is a digital therapeutic (DTx), developed by Synaptikon GmbH, used for mild cognitive impairment. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR229.00/90-day Rx (diga.bfarm.de).

NichtraucherHelden-App is a digital therapeutic (DTx), developed by NichtraucherHelden GmbH, used for smoking cessation. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR211.00/90-day Rx (diga.bfarm.de).

Novego: Ängste überwinden is a digital therapeutic (DTx), developed by IVPNetworks GmbH, used for anxiety disorder. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA (one-off licence); manufacturer price EUR189.00 one-off licence (diga-verzeichnis.de).

Novego: Depressionen bewältigen is a digital therapeutic (DTx), developed by IVPNetworks GmbH, used for depression. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA (one-off licence); manufacturer price EUR199.00 one-off licence (diga-verzeichnis.de).

ORIKO ADHS-Therapie is a digital therapeutic (DTx), developed by Oriko GmbH, used for ADHD (adults). It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA (provisional); manufacturer price EUR360.00/90-day Rx (diga.bfarm.de).

Oviva Direkt Bluthochdruck is a digital therapeutic (DTx), developed by Oviva AG, used for hypertension. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA (provisional); manufacturer price EUR599.00/90-day Rx (diga.bfarm.de).

Oviva Direkt für Adipositas is a digital therapeutic (DTx), developed by Oviva AG, used for obesity. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR243.00/90-day Rx (diga-verzeichnis.de).

PINK! Coach is a digital therapeutic (DTx), developed by PINK! gegen Brustkrebs GmbH, used for breast cancer (psycho-oncology). It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR234.50/90-day Rx (diga.bfarm.de).

priovi is a digital therapeutic (DTx), developed by GAIA AG, used for borderline personality disorder. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR244.00/90-day Rx (diga.bfarm.de).

ProHerz is a digital therapeutic (DTx), developed by ProCarement GmbH, used for heart failure. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR235.00/90-day Rx (diga.bfarm.de).

Selfapys Online-Kurs bei Binge-Eating-Störung is a digital therapeutic (DTx), developed by Selfapy GmbH, used for binge eating disorder. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR232.00/90-day Rx (diga-verzeichnis.de).

Selfapys Online-Kurs bei Bulimia Nervosa is a digital therapeutic (DTx), developed by Selfapy GmbH, used for bulimia nervosa. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR232.00/90-day Rx (diga.bfarm.de).

Selfapys Online-Kurs bei Depression is a digital therapeutic (DTx), developed by Selfapy GmbH, used for depression. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR217.18/90-day Rx (diga.bfarm.de).

Selfapys Online-Kurs bei Generalisierter Angststörung is a digital therapeutic (DTx), developed by Selfapy GmbH, used for generalised anxiety disorder. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR228.50/90-day Rx (diga-verzeichnis.de).

Smoke Free - Rauchen aufhören is a digital therapeutic (DTx), developed by Smoke Free 23 GmbH (parent: 23 Ltd, UK), used for smoking cessation. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR231.25/90-day Rx (diga-verzeichnis.de).

somnio is a digital therapeutic (DTx), developed by mementor DE GmbH, used for insomnia. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR224.99/90-day Rx (diga.bfarm.de).

somnovia is a digital therapeutic (DTx), developed by GAIA AG, used for chronic insomnia. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR236.00/90-day Rx (diga.bfarm.de).

Una Health für Diabetes is a digital therapeutic (DTx), developed by Una Health GmbH, used for type 2 diabetes. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA (provisional); manufacturer price EUR740.00/90-day Rx (diga-verzeichnis.de).

Untire(R) is a digital therapeutic (DTx), developed by Tired of Cancer B.V. (Untire), used for cancer-related fatigue. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR240.50/90-day Rx (diga.bfarm.de).

velibra is a digital therapeutic (DTx), developed by GAIA AG, used for anxiety disorder. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR230.00/90-day Rx (diga.bfarm.de).

Vera-App für Wechseljahresbeschwerden is a digital therapeutic (DTx), developed by Endo Health GmbH, used for menopause symptoms. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA (provisional); manufacturer price EUR598.95/90-day Rx (diga-verzeichnis.de).

Vitadio is a digital therapeutic (DTx), developed by Vitadio, used for type 2 diabetes. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR224.01/90-day Rx (diga.bfarm.de).

Vivira is a digital therapeutic (DTx), developed by Vivira Health Lab GmbH, used for back pain. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR206.79/90-day Rx (diga.bfarm.de).

vorvida is a digital therapeutic (DTx), developed by GAIA AG, used for alcohol use disorder. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR185.00/90-day Rx (diga.bfarm.de).

zanadio is a digital therapeutic (DTx), developed by aidhere GmbH, used for obesity. It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA; manufacturer price EUR218.00/90-day Rx (diga.bfarm.de).

Implicity is a remote-monitoring / digital health platform, developed by Implicity SAS, used for cardiac arrhythmia / cardiac implantable device monitoring. It is reimbursed nationally in France via the PECAN pathway. PECAN: EUR435 first 3 months then EUR38.30/month, max EUR780/yr.

Newcard is a remote-monitoring / digital health platform, developed by Newcard, used for cardiac remote monitoring. It is reimbursed nationally in France via the PECAN pathway. PECAN: EUR435 first 3 months then EUR38.30/month, max EUR780/yr (standard PECAN telesurveillance tariff, same schedule as Implicity).

Predict4Health is a remote-monitoring / digital health platform, developed by Predict4Health, used for cardiac & renal deterioration prediction (AI). It is reimbursed nationally in France via the PECAN pathway. PECAN: EUR435 first 3 months then EUR38.30/month, max EUR780/yr (standard PECAN telesurveillance tariff, same schedule as Implicity).

Semeia is a remote-monitoring / digital health platform, developed by Semeia, used for chronic kidney disease remote monitoring. It is reimbursed nationally in France via the PECAN pathway. PECAN: EUR435 first 3 months then EUR38.30/month, max EUR780/yr (standard PECAN telesurveillance tariff, same schedule as Implicity).

Careline is a remote-monitoring / digital health platform, developed by Careline, used for cardiac remote monitoring. It is reimbursed nationally in France via the PECAN pathway. PECAN: EUR435 first 3 months then EUR38.30/month, max EUR780/yr (standard PECAN telesurveillance tariff, same schedule as Implicity).

Healabs is a remote-monitoring / digital health platform, developed by Healabs, used for cardiac & renal remote monitoring. It is reimbursed nationally in France via the PECAN pathway. PECAN: EUR435 first 3 months then EUR38.30/month, max EUR780/yr (standard PECAN telesurveillance tariff, same schedule as Implicity).

MHComm is a remote-monitoring / digital health platform, developed by MHComm, used for cardiac & renal remote monitoring platform (multi-pathology). It is reimbursed nationally in France via the PECAN pathway. PECAN: EUR435 first 3 months then EUR38.30/month, max EUR780/yr (standard PECAN telesurveillance tariff, same schedule as Implicity).

Comunicare is a remote-monitoring / digital health platform, developed by Comunicare, used for cardiac & renal remote monitoring. It is reimbursed nationally in France via the PECAN pathway. PECAN: EUR435 first 3 months then EUR38.30/month, max EUR780/yr (standard PECAN telesurveillance tariff, same schedule as Implicity).

JOE (Digital Therapy JOE) is a connected medical device (with companion software), developed by Ludocare SAS, used for persistent paediatric asthma (ages 3-10). It is reimbursed nationally in France via the LPPR pathway. Pending: CEPS price negotiation, then publication in Journal Officiel before reimbursement is active.

Diabeloop DBLG1 is a connected medical device (with companion software), developed by Diabeloop SA, used for type 1 diabetes (inadequate control on insulin pump). It is reimbursed nationally in France via the LPPR pathway. LPPR codes 1177410 (terminal) & 1102872 (daily algorithm licence); limited to adults with >6 months intensive insulin pump therapy and insufficient glycaemic control.

Poppins Clinical is a digital therapeutic (DTx), developed by BMOTION Technologies (brand: Poppins; formerly Mila until Oct 2023), used for dyslexia and related learning disorders, children 7-11. It is reimbursed nationally in France via the PECAN pathway. PECAN tariff: EUR435 flat fee first 3 months, then EUR38.30/month, max EUR780/yr.

RESILIENCE PRO is a remote-monitoring / digital health platform, developed by Resilience, used for oncology remote monitoring and supportive care. Helps patients cope with treatment side effects and improves quality of life during and after cancer treatment. It is reimbursed nationally in France via the PECAN pathway. Reimbursed under the French telesurveillance framework since Oct 2023; exact CEPS tariff not independently confirmed in this pass.

FibriCheck is a remote-monitoring / digital health platform, developed by FibriCheck NV, used for atrial fibrillation / arrhythmia detection (smartphone PPG). It is reimbursed nationally in Belgium.

Remecare is a remote-monitoring / digital health platform, developed by Newexo / Remecare, used for chronic heart failure remote monitoring & coaching. It is reimbursed nationally in Belgium.

moveUp is a remote-monitoring / digital health platform, developed by moveUP NV, used for multi-domain digital care platform, NOT heart-failure-specific. Per the product's own mHealthBELGIUM listing: orthopaedics (arthroplasty and conservative treatment), cardiology (surgery and heart failure), oncology (haematology), abdominal surgery, obesity, respiratory (COPD, asthma) and neurology; personalised care plans, education and monitoring tools across all of these. It is reimbursed nationally in Belgium.

Healthentia is a remote-monitoring / digital health platform, developed by Innovation Sprint, used for digital biomarkers / remote monitoring (multi-pathology, incl. Heart failure). It is reimbursed nationally in Belgium.

BeWell Well@Home is a remote-monitoring / digital health platform, developed by BeWell Innovations, used for chronic heart failure remote monitoring. Questionnaires, connected vital-sign measurement, education, diary, secure messaging and video consultation with the care team. It is reimbursed nationally in Belgium.

Comarch HomeHealth 2.0 is a remote-monitoring / digital health platform, developed by Comarch AG - Belgian Branch, used for chronic heart failure and other chronic-disease remote monitoring. It is reimbursed nationally in Belgium.

Comunicare is a remote-monitoring / digital health platform, developed by Comunicare Solutions, used for chronic-disease communication and self-management. Cancer, heart failure, COPD, multiple myeloma and other chronic conditions (multi-indication digital care companion, not heart-failure-specific). It is reimbursed nationally in Belgium.

CareLink System is a remote-monitoring / digital health platform, developed by Medtronic Belgium (Medtronic plc), used for pacemaker / ICD / CRT-D / CRT-P follow-up (cardiac implantable electronic devices), via the MyCareLink Heart app or a bedside monitor. It is reimbursed nationally in Belgium.

Noona is a remote-monitoring / digital health platform, developed by Varian Medical Systems Belgium (Siemens Healthineers group), used for oncology patient-reported outcomes. Symptom tracking and secure messaging with the cancer care team during treatment, recovery and post-treatment care. It is reimbursed nationally in Belgium.

Plateforme Maela is a remote-monitoring / digital health platform, developed by Medtronic Belgium (Medtronic plc), used for multi-specialty surgical patient engagement and monitoring. Configurable digital care protocols for colorectal, bariatric, spine, AFS and thoracic surgery pathways, among others. It is reimbursed nationally in Belgium.

RESILIENCE PRO is a remote-monitoring / digital health platform, developed by Resilience, used for oncology remote monitoring and supportive care. Helps patients cope with treatment side effects and improves quality of life during and after cancer treatment. It is reimbursed nationally in Belgium.

1 Minute pour mon Coeur is a remote-monitoring / digital health platform, developed by Newcard, used for chronic heart failure remote monitoring. Physiological parameters (weight, blood pressure, heart rate) collected via a patient kit and reviewed by the treating care team. It is reimbursed nationally in Belgium.

FreeStyle Libre Flash Glucose Monitoring System (BE) is a connected medical device (with companion software), developed by Abbott SA/NV, used for interstitial glucose measurement for people (4+) with diabetes mellitus, including pregnant women; replaces blood-glucose testing for insulin dosing. It is reimbursed nationally in Belgium.

deprexis (CH) is a digital therapeutic (DTx), developed by GAIA AG, used for mild-to-moderate depression, recurrent depressive disorders. It is reimbursed nationally in Switzerland via the MiGeL/dGA listing (OKP compulsory insurance). OKP (Obligatorische Krankenpflegeversicherung, compulsory health insurance) covers a Höchstvergütungsbetrag (HVB, max. reimbursement amount) of CHF193.32 out of a CHF271.32 total price; the remaining Selbstbehalt (co-payment) is often covered by supplementary insurance (Zusatzversicherung); requires prescription by a psychiatry/psychotherapy specialist or a...

Vigo is a digital therapeutic (DTx), developed by Vigo Health, used for post-stroke rehabilitation (multimodal: physical therapy, activities-of-daily-living guidance, CBT-based tools), for patients who have not entirely lost cognitive ability. It is reimbursed nationally in Latvia via an NVD (National Health Service) manipulation-list code. Uncertain / not independently confirmed for 2025-2026 -- see note above.

BIOTRONIK Home Monitoring is a connected medical device (with companion software), developed by BIOTRONIK SE & Co. KG, used for pacemaker / ICD / CRT follow-up (cardiac implantable electronic devices). It is reimbursed nationally in Germany via nationwide EBM remote-monitoring/telemonitoring billing codes. Reimbursed since 1 April 2016.

Medtronic CareLink Network is a connected medical device (with companion software), developed by Medtronic plc, used for pacemaker / ICD / CRT follow-up. It is reimbursed nationally in Germany via nationwide EBM remote-monitoring/telemonitoring billing codes. Reimbursed since 1 April 2016.

Boston Scientific LATITUDE NXT is a connected medical device (with companion software), developed by Boston Scientific Corporation, used for pacemaker / ICD / CRT follow-up. It is reimbursed nationally in Germany via nationwide EBM remote-monitoring/telemonitoring billing codes. Reimbursed since 1 April 2016.

Abbott Merlin.net is a connected medical device (with companion software), developed by Abbott Laboratories (legacy St. Jude Medical), used for pacemaker / ICD / CRT follow-up. It is reimbursed nationally in Germany via nationwide EBM remote-monitoring/telemonitoring billing codes. Reimbursed since 1 April 2016.

SaniQ HERZ is a connected medical device (with companion software), developed by Qurasoft GmbH, used for chronic heart failure remote monitoring (external measurement devices). It is reimbursed nationally in Germany via nationwide EBM remote-monitoring/telemonitoring billing codes. Reimbursed since Jan 2022 (G-BA resolution 2020).

hedy Telemonitoring is a connected medical device (with companion software), developed by Health Care Systems GmbH (HCSG), used for chronic heart failure remote monitoring (external measurement devices). It is reimbursed nationally in Germany via nationwide EBM remote-monitoring/telemonitoring billing codes. Reimbursed since Jan 2022.

telecor (SHL Telemedizin) is a connected medical device (with companion software), developed by SHL Telemedizin GmbH (part of SHL Group), used for chronic heart failure remote monitoring, TMZ-as-a-service for cardiologists. It is reimbursed nationally in Germany via nationwide EBM remote-monitoring/telemonitoring billing codes. Reimbursed since Jan 2022.

FreeStyle Libre (2 / 3) is a connected medical device (with companion software), developed by Abbott Diabetes Care, used for insulin-treated diabetes (type 1 and insulin-treated type 2). It is reimbursed nationally in Germany via nationwide EBM remote-monitoring/telemonitoring billing codes. Reimbursed since 2016 (Libre); Libre 2 added 2019.

Dexcom G6 / G7 is a connected medical device (with companion software), developed by Dexcom Inc., used for insulin-treated diabetes. It is reimbursed nationally in Germany via nationwide EBM remote-monitoring/telemonitoring billing codes. Reimbursed (individual case approval by Krankenkasse).

Preventicus Heartbeats is a digital prevention programme, developed by Preventicus GmbH, used for atrial fibrillation screening (stroke prevention), insured persons 55+. It is reimbursed in Germany through regional or insurer-specific contracts rather than a nationwide scheme.

Online-Hautcheck (OnlineDoctor) is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by OnlineDoctor AG, used for skin conditions / suspicious moles. Asynchronous photo-based dermatology consultation. It is reimbursed in Germany through regional or insurer-specific contracts rather than a nationwide scheme.

TK-Doc is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by Techniker Krankenkasse (TK) -- operated in-house, not a separate vendor company, used for general/primary-care consultation via live chat or phone, in lieu of a waiting-room visit. It is reimbursed in Germany through regional or insurer-specific contracts rather than a nationwide scheme.

dermanostic is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by dermanostic GmbH, used for skin conditions incl. acne, eczema, psoriasis, suspicious moles. Photo + questionnaire teledermatology, reviewed by a board-certified dermatologist. It is reimbursed in Germany through regional or insurer-specific contracts rather than a nationwide scheme.

Curafida (ZTM Bad Kissingen) is a remote-monitoring / digital health platform, developed by ZTM Bad Kissingen GmbH (Zentrum für Telemedizin e.V. / Stiftung Innovative Gesundheitsversorgung), used for chronic heart-failure remote monitoring (vital-sign telemonitoring); platform also used for other indications e.g. Multiple sclerosis ('MS-intakt'). It is reimbursed nationally in Germany via nationwide EBM remote-monitoring/telemonitoring billing codes. Reimbursed since Jan 2022 where a contracted physician bills the national HFTM codes; the sekTOR-HF Innovationsfonds pilot itself (Jun...

Thieme TeleCare (Thieme TeleCoach App) is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by Thieme TeleCare GmbH (subsidiary of the Thieme Verlagsgruppe medical-publishing group; telemedicine coaching provider active since 2000, company states 75,000+ people supported to date), used for multi-condition telemedical coaching: respiratory disease, hypertension/heart health, Long Covid/fatigue, diabetes, overweight, chronic pain, mental health/stress, sleep and more. It is reimbursed in Germany through regional or...

AnyHand (LIME medical) is a connected medical device (with companion software), developed by LIME medical GmbH, used for post-injury hand/finger rehabilitation aftercare (bone, tendon, ligament injuries). Robotic-assisted motion therapy. It is reimbursed in Germany case-by-case through statutory accident insurance.

Herodikos (Herodikos App / Herakles) is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by Herodikos GmbH (Varel, Niedersachsen, 2019), used for back pain, neck pain, knee pain. It is reimbursed in Germany through regional or insurer-specific contracts rather than a nationwide scheme.

Ongoing (no fixed programme length found)

medicalmotion is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by medicalmotion GmbH (Munich, 2017, founders Sven & Tobias Klimpel), used for back and knee pain. It is reimbursed in Germany through regional or insurer-specific contracts rather than a nationwide scheme.

Ongoing (no fixed programme length found)

Fimo Health is a digital therapeutic (DTx), developed by Fimo Health GmbH (Bonn, founded 30 Dec 2019), used for long Covid, ME/CFS, cancer, multiple sclerosis, fibromyalgia, rheumatoid arthritis (chronic-disease companion, not single-indication). It is reimbursed in Germany through regional or insurer-specific contracts rather than a nationwide scheme.

6 months (mhplus Krankenkasse); duration at other partner funds not centrally published

Mika (Krebs Therapie Assistent) is a digital health solution, developed by Fosanis GmbH, used for psycho-oncology support, initially ovarian/cervical/endometrial cancer. It is not currently reimbursed in Germany -- WITHDRAWN.

N/A (delisted)

Selfapys Online-Kurs bei Panikstörung is a digital health solution, developed by Selfapy GmbH, used for panic disorder. It is not currently reimbursed in Germany -- WITHDRAWN by end of Sept 2023.

N/A (delisted)

mentalis is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by mentalis GmbH (Nuremberg, founded 2018; founders Alexander Ploner, Leonhard Glomann, Dr. Christian A. Lukas, Hans-Jürgen Stein), used for depression (programme 'Phoenix'), eating disorders ('MyJourney'), borderline personality disorder ('InBalance'), emotional-competence training ('TEK'). Algorithm-based therapy app + tele-coaching, set up on the patient's phone before hospital discharge, 26 weeks active + 6 months read-only. It is reimbursed in Germany through...

26 weeks active access + 6 months read-only follow-up

neotivCare is a remote-monitoring / digital health platform, used for 3 validated cognitive/memory tests over 12 weeks, tablet/smartphone-based, distinguishes age-related from disease-related memory decline. It is reimbursed in Germany through regional or insurer-specific contracts rather than a nationwide scheme.

12 weeks (3 cognitive/memory tests)

Skinuvita is a digital therapeutic (DTx), developed by Skinuvita GmbH (Bremen, founded 2021; backed by High-Tech Gründerfonds and private investors incl. Stefan Bellinger; EUR1.8m raised), used for digital therapy SYSTEM: smart home UV-irradiation device (hardware) + telemonitoring by participating dermatologists. Moves UV phototherapy, previously clinic/practice-only, into the home. It is reimbursed in Germany through regional or insurer-specific contracts rather than a nationwide scheme.

Not specified (pilot phase, ongoing)

eatappie is a digital therapeutic (DTx), developed by Mind Generation GmbH (Heidelberg, founded Sept 2023 -- EXIST-Gründerstipendium spin-off; founders Dr. med. Larissa Niemeyer and Dr. med. Szarah Sanchez Roman, ex-Zentralinstitut für Seelische Gesundheit), used for anorexia and bulimia nervosa in adolescents (12-18); digital CBT-based companion, bridges waiting times and supports post-inpatient follow-up. It is reimbursed in Germany through regional or insurer-specific contracts rather than a nationwide scheme.

Not specified (ongoing access while TK-insured)

myReha is a digital therapeutic (DTx), developed by nyra health GmbH (Vienna, Austria, founded 2020; founders Moritz Schöllauf, Mario Zusag, Philipp Schöllauf; EUR20m Series A), used for speech, cognition, memory and everyday-skills therapy for neurological conditions: aphasia, stroke, traumatic brain injury, dementia; 65,000+ adaptive exercises. It is reimbursed in Germany through regional or insurer-specific contracts rather than a nationwide scheme.

6 months (per licence)

Nukkuaa (aka sleep(2)) is a digital therapeutic (DTx), developed by Nukkuaa GmbH (Salzburg, Austria, founded 2022; spin-off of Paris-Lodron-Universität Salzburg; founders Prof. Manuel Schabus and Dr. Thomas Winkler), used for insomnia / sleep-quality improvement. Overnight heart-rate sensor (Polar strap or Apple Health/Google Fit) + algorithmic sleep-stage analysis + evidence-based sleep training. It is reimbursed in Germany through regional or insurer-specific contracts rather than a nationwide scheme.

12 months (1 year, free for TK-insured)

FEMNA Care is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by Femna Health M.E. GmbH (Berlin, founded 2016 by Maxie Matthiessen and Emily Casey), used for endometriosis, PCOS, PMS/PMDD, menstrual pain/cycle complaints, menopause. Includes 3 individual coaching sessions with medical professionals per programme. It is reimbursed in Germany through regional or insurer-specific contracts rather than a nationwide scheme.

12 months (VIACTIV); duration at other partner funds not centrally published

neolexon Artikulations-App is a digital therapeutic (DTx), developed by neolexon GmbH, used for articulation-disorder home-training app for children aged 3-7 already in speech-language-pathology (Logopädie) treatment; used to supplement, not replace, in-person SLP sessions. It is reimbursed in Germany through regional or insurer-specific contracts rather than a nationwide scheme.

3 or 6 months (licence; pricing scales with duration)

LipoAlly is a digital therapeutic (DTx), used for 12-month lipedema (Lipödem) companion programme. Video modules with medicine/therapy/psychology experts, monthly live courses, movement units, progress documentation. It is reimbursed in Germany through regional or insurer-specific contracts rather than a nationwide scheme.

12 months

OvulaRing is a remote-monitoring / digital health platform, used for cycle/ovulation tracking for women with irregular menstruation or unfulfilled desire to have children. Wearable vaginal-ring hormone sensor + companion app; NOTE: this is hardware + app, closer to the RPM/telemonitoring category than a pure software DTx, included here because its reimbursement mechanism (per-insurer Kostenerstattung) matches this sheet's other entries. It is reimbursed in Germany through regional or insurer-specific contracts rather than a nationwide scheme.

12 months (annual reimbursement cap, renewable)

Nia is a digital therapeutic (DTx), developed by Nia Health GmbH (Berlin; spun out of Charite Berlin, 2019; partnered with Sanofi/Sanofi Genzyme), used for atopic dermatitis / neurodermitis (ICD L20). AI-based skin-condition documentation, flare-trigger identification, personalised recommendations, follows the AGNES neurodermitis-training curriculum. It is reimbursed in Germany through regional or insurer-specific contracts rather than a nationwide scheme.

6 or 12 months (package-dependent -- 'Digitale Begleitung' vs 'Tagebuch PLUS')

Breathment is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, used for COPD (also asthma). AI-guided breathing/stretching/mobilisation exercises via phone camera with live audio/visual form feedback, plus a physiotherapist-staffed chat/video-consultation layer (app + human hybrid, not software-only). It is reimbursed in Germany through regional or insurer-specific contracts rather than a nationwide scheme.

3, 6, or 12 months (tiered -- EUR100/EUR200/EUR400 respectively)

Caterna Vision is a digital therapeutic (DTx), developed by Caterna Vision GmbH (Berlin), used for amblyopia ('lazy eye'), children aged 4-12. Online vision-training games using a background wave pattern intended to stimulate the brain-eye connection, ~30-45 min/day, ophthalmologists can monitor progress online. It is reimbursed in Germany through regional or insurer-specific contracts rather than a nationwide scheme.

3 months (fixed therapy period)

eCovery (AOK PLUS Satzungsleistung -- non-DiGA indications) is a digital therapeutic (DTx), developed by eCovery GmbH (same manufacturer as the lower-back DiGA), used for upper back pain, hip pain, knee pain (incl. Osteoarthritis/cartilage wear, meniscus issues) and pre-/post-operative care for total hip or knee replacement (TEP); TEP patients pay a EUR99 co-payment out of a EUR399 total, all other indications fully covered up to the EUR300 cap. It is reimbursed in Germany through regional or insurer-specific contracts rather than a nationwide scheme.

12 months (annual benefit cap)

ActiveTEP (Hüfte / Knie) is a digital therapeutic (DTx), developed by DORA Digitale Orthopädie Anwendungen GmbH (Leipzig); part of the EU-co-funded 'Health Labs4Value' research project, also co-financed by the Free State of Saxony, used for total hip replacement (ActiveTEP Hüfte) and total knee replacement (ActiveTEP Knie). 24-week companion (12 weeks pre-op + 12 weeks post-op): 60+ knowledge modules, training plans, diary/progress tracking; the knee version followed the hip version to market. It is reimbursed in Germany through regional or insurer-specific contracts rather than a...

24 weeks (12 weeks pre-op + 12 weeks post-op)

HELP (HELP Schmerztherapie) is a digital therapeutic (DTx), developed by HELP Mee Schmerztherapie GmbH (founder/CEO Dr. med. Antje Kallweit, specialist in anaesthesiology / special pain therapy), used for chronic 'nociplastic' pain (i.e. pain sustained by nervous-system processing rather than ongoing tissue damage). Fibromyalgia, chronic back/neck pain, persistent pelvic pain, or pain that persists after an injury/surgery has otherwise healed; 90-day, 24-module programme covering pain-neuroscience education, neuroplasticity-based exercises, and behavioural-medicine techniques; earmarked...

90 days (24-module programme); 5-day trial option also available

Uroletics is a digital therapeutic (DTx), developed by Rocketlane Medical Ventures GmbH (majority stake acquired by APOGEPHA Arzneimittel GmbH, Dec 2022), used for pre- and post-operative care for prostate surgery. 3D pelvic-floor training, mental-coaching content for surgery preparation and coping, and validated patient information, aimed at preventing/treating post-operative incontinence and erectile dysfunction. It is reimbursed in Germany through regional or insurer-specific contracts rather than a nationwide scheme.

Not specified (ongoing access under the active Barmenia PKV contract)

actensio is a digital therapeutic (DTx), developed by mementor DE GmbH (same manufacturer as the still-active DiGA 'somnio'), used for hypertension (high blood pressure). It is available in Germany on a self-pay basis -- a reimbursement-eligible pathway may exist, but the patient currently pays out of pocket rather than an insurer or employer.

N/A (delisted); self-pay commercial pricing was quoted per 90 days

Kaia COPD: Meine aktive COPD Therapie is a digital therapeutic (DTx), developed by Kaia Health Software GmbH (acquired by Sword Health, Jan 2026), used for COPD (chronic obstructive pulmonary disease). Breathing/relaxation/movement exercise programme with an AI-based camera exercise coach. It is reimbursed in Germany through regional or insurer-specific contracts rather than a nationwide scheme.

90 days (per activation code)

MindDoc Auf Rezept is a digital health solution, developed by MindDoc Health GmbH, used for depression. It is not currently reimbursed in Germany -- WITHDRAWN by MindDoc's own decision.

N/A (delisted)

MindDoc: Psychotherapie per Video is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by MindDoc Health GmbH (a Schön Klinik online offering since 2015, effectiveness researched with LMU Munich), used for depression, eating disorders, anxiety disorders, obsessive-compulsive disorder. Initial diagnostic assessment at one of 200+ partner practices nationwide, then a fixed weekly video therapy slot with a licensed psychotherapist (full outpatient behavioural therapy, not just self-help content), plus a crisis hotline and access...

Not fixed (ongoing outpatient psychotherapy; duration set by clinical need)

My Dose Coach is a digital health solution, developed by METEDA s.r.l. (Italy); marketed in Germany by Sanofi, used for type 2 diabetes on long-acting basal insulin (or basal insulin + GLP-1 fixed combination). Physician sets a dosing plan via a portal, patient logs fasting blood glucose and receives daily insulin-dose guidance. It is not currently reimbursed in Germany -- Delisted.

N/A (delisted)

Orthopy bei Knieverletzungen is a digital health solution, developed by Orthopy Health GmbH, used for knee injuries / rehabilitation. It is not currently reimbursed in Germany -- WITHDRAWN 9 Sep 2025.

N/A (delisted)

re.flex is a digital health solution, developed by Kineto Tech Rehab SRL (Romania), used for knee osteoarthritis (gonarthrosis). Sports/movement therapy, developed with Sporlastic Medizinische Produkte GmbH. It is not currently reimbursed in Germany -- Delisted.

N/A (delisted)

Selfapys Online-Kurs bei chronischen Schmerzen is a digital health solution, developed by Selfapy GmbH, used for chronic pain. CBT-based methods and techniques. It is not currently reimbursed in Germany -- WITHDRAWN 28 May 2025.

N/A (delisted)

Lindera Mobilitätsanalyse (Sturz-App) is a digital prevention programme, developed by Lindera GmbH, used for fall-risk assessment / mobility analysis in older adults. AI analyses gait from a short smartphone-camera video to calculate individual fall risk, used mainly in nursing/care settings by staff, with results reviewed by clinicians/therapists for fall-prevention planning; Charite-affiliated study cites up to 15-20% fall-risk reduction. It is reimbursed in Germany through regional or insurer-specific contracts rather than a nationwide scheme.

Not specified (ongoing access in care setting)

Caspar Health (digitale Reha-Nachsorge) is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by Caspar Health GmbH, used for general post-rehabilitation aftercare (multi-indication). Structured digital follow-on care after orthopaedic, cardiac, oncological, psychosomatic and other rehab stays, intended to sustain therapy gains after discharge. It is reimbursed in Germany through the statutory pension/care-insurance system rather than standard health insurance.

Not fixed (duration tied to individual DRV aftercare period)

EvoCare is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by EvoCare Telemedizin ECT eG (Nuremberg/Erlangen area, Germany; own site states founded 2018, though the underlying telemedicine methodology traces to DRV-funded research at Fachklinik Herzogenaurach from ~1999-2004), used for multimodal digital rehabilitation aftercare across orthopaedics (chronic back pain, joint-replacement aftercare), cardiology (coronary heart disease secondary prevention), neurology (aphasia, stroke, cognitive/attention training) and general...

Not fixed (duration tied to individual DRV aftercare period)

Prothera Fit is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, used for multimodal and training-therapy digital rehabilitation aftercare, prevention and rehabilitation content (app-based, iOS/Android); specific indication breadth not independently itemised in this pass. It is reimbursed in Germany through the statutory pension/care-insurance system rather than standard health insurance.

Not fixed (duration tied to individual DRV aftercare period)

Flowzone is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by Flow Technologies (Oslo, Norway -- not a German company, but operates as a DRV-recognised aftercare provider in Germany), used for digital rehabilitation aftercare with 600+ exercises/seminars for orthopaedic and cardiac indications. It is reimbursed in Germany through the statutory pension/care-insurance system rather than standard health insurance.

Not fixed (duration tied to individual DRV aftercare period)

MyMEDIAN@Home is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by MEDIAN Kliniken (major German rehabilitation-clinic operator group; in-house developed), used for all somatic rehabilitation conditions (24 training/wellbeing/knowledge modules) plus a dedicated neurological track (36 modules). It is reimbursed in Germany through the statutory pension/care-insurance system rather than standard health insurance.

Up to 12 months post-rehab

eduMovo is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, used for multimodal digital rehabilitation aftercare. Interactive learning units, individual training plans, task management, chat/video contact with the aftercare team. It is reimbursed in Germany through the statutory pension/care-insurance system rather than standard health insurance.

Not fixed (duration tied to individual DRV aftercare period)

DE-RENA / DE-RENA 2.0 is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by Binacon GmbH (Mannheim, Germany), used for psychosomatic Reha-Nachsorge for depressive disorders. (smartphone) app supporting individual daily-structure planning to help patients sustain newly-learned coping behaviours after psychosomatic rehab, with regular contact to an assigned aftercare therapist. It is reimbursed in Germany through the statutory pension/care-insurance system rather than standard health insurance.

Not fixed (duration tied to individual DRV aftercare period)

myReha (DRV Reha-Nachsorge) is a digital therapeutic (DTx), developed by nyra health GmbH (Vienna, Austria, founded 2020; founders Moritz Schöllauf, Mario Zusag, Philipp Schöllauf; EUR20m Series A), used for same speech, cognition, memory and everyday-skills therapy for neurological conditions (aphasia, stroke, traumatic brain injury, dementia, Parkinson's, MS) as the GKV-Selektivvertrag offering, delivered as DRV-funded post-rehab aftercare instead. ~50,000 patients across 100+ clinics, ~98% satisfaction reported in a DRV pilot. It is reimbursed in Germany through the statutory...

Not fixed (duration tied to individual DRV aftercare period)

Health Hero (Long-COVID-Service) is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by HealthHero Germany GmbH (formerly Fernarzt; part of the pan-European HealthHero group since 2020), used for long-COVID / Post-COVID syndrome. Digital symptom-checker followed by a specialist video consultation with Long-COVID-trained doctors, plus an optional independent-rehabilitation coaching track. It is reimbursed in Germany through regional or insurer-specific contracts rather than a nationwide scheme.

Not specified (symptom-check + consultation, plus optional coaching track)

Das Lab (DasLab) is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, used for colorectal cancer screening. At-home stool test, digital lab report, and (for positive results) a video consultation with a telemedicine physician plus onward referral. It is reimbursed in Germany through regional or insurer-specific contracts rather than a nationwide scheme.

One-time screening (not an ongoing programme)

Remi Health (HPV-Heimtest) is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by Remi Health GmbH (myremi.com), used for cervical cancer screening. At-home HPV self-sampling kit (tests HPV 16, HPV 18 plus 12 further high-risk types), digital result delivery, and telephone consultation with a Remi-network gynaecologist for abnormal results. It is reimbursed in Germany through regional or insurer-specific contracts rather than a nationwide scheme.

One-time screening (not an ongoing programme)

neolexon Aphasie-App is a digital therapeutic (DTx), developed by neolexon GmbH, used for aphasia therapy. Home-training app for adults with aphasia (post-stroke or other acquired brain injury), used to supplement, not replace, in-person speech-language-pathology (Logopädie) sessions. It is reimbursed in Germany through regional or insurer-specific contracts rather than a nationwide scheme.

Not specified (ongoing supplement to in-person speech therapy)

YoniCare (Micado) is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by Micado Health Care GmbH (Hamburg, founded 13 Aug 2004), used for genitourinary syndrome of menopause (GSM). Vaginal dryness, tissue/mucosal changes, itching, incontinence and recurrent UTIs from declining oestrogen; laser therapy revitalises the vaginal epithelium, typically 1-3 sessions 4-8 weeks apart, hormone-free. It is reimbursed in Germany through regional or insurer-specific contracts rather than a nationwide scheme.

1-3 sessions, spaced 4-8 weeks apart

FreeStyle LibreLink (GB) is a connected medical device (with companion software), developed by Abbott Diabetes Care, used for type 1 diabetes (all ages); insulin-treated type 2 diabetes meeting local eligibility criteria. It is reimbursed nationally in the United Kingdom via the NICE NG17 pathway. Reimbursed (NHS-funded sensor; companion app free) -- NICE NG17 recommends offering rtCGM or isCGM to ALL adults/children with type 1 diabetes based on individual preference and device functionality; insulin-treated type 2 diabetes covered under narrower local-ICB criteria (typically multiple...

Dexcom Clarity (Dexcom G6/G7, GB) is a connected medical device (with companion software), developed by Dexcom Inc., used for type 1 diabetes (all ages); insulin-treated type 2 diabetes meeting local eligibility criteria. It is reimbursed nationally in the United Kingdom via the NICE NG17 pathway. Reimbursed (NHS-funded sensor; companion app free) -- Same NICE NG17 national pathway as FreeStyle LibreLink above; Dexcom G6/G7 sensors prescribed via NHS diabetes services, Dexcom Clarity is the free companion analytics app (also has a clinician-facing web platform).

Beating the Blues is a digital therapeutic (DTx), used for depression and generalised anxiety disorder (GAD). It is reimbursed nationally in the United Kingdom via the NHS Talking Therapies DET pathway. NHS England DET-compliant, nationally usable within NHS Talking Therapies -- Commissioned locally by individual NHS Talking Therapies services, drawn from NICE's nationally-vetted DET list -- same national-mandate/local-choice structure as NG17 CGM.

SilverCloud (Space from Depression / Space from Anxiety) is a digital therapeutic (DTx), developed by SilverCloud Health, used for depression and anxiety/GAD. It is reimbursed nationally in the United Kingdom via the NHS Talking Therapies DET pathway. NHS England DET-compliant, nationally usable within NHS Talking Therapies -- Commissioned locally by individual NHS Talking Therapies services, drawn from NICE's nationally-vetted DET list; NOTE -- distinct from this same company's separate 'SilverCloud - Making Space for Healthy Minds' listing on the 'UK - ORCHA Recommended Apps' tab (a...

Koa Health iCT-PTSD is a digital therapeutic (DTx), developed by Koa Health, used for post-traumatic stress disorder (PTSD). It is reimbursed nationally in the United Kingdom via the NHS Talking Therapies DET pathway. NHS England DET-compliant, nationally usable within NHS Talking Therapies -- Commissioned locally by individual NHS Talking Therapies services, drawn from NICE's nationally-vetted DET list.

Koa Health iCT-SAD is a digital therapeutic (DTx), developed by Koa Health, used for social anxiety disorder (SAD). It is reimbursed nationally in the United Kingdom via the NHS Talking Therapies DET pathway. NHS England DET-compliant, nationally usable within NHS Talking Therapies -- Commissioned locally by individual NHS Talking Therapies services, drawn from NICE's nationally-vetted DET list.

Spring is a digital therapeutic (DTx), used for post-traumatic stress disorder (PTSD). It is reimbursed nationally in the United Kingdom via the NHS Talking Therapies DET pathway. NHS England DET-compliant, nationally usable within NHS Talking Therapies -- Commissioned locally by individual NHS Talking Therapies services, drawn from NICE's nationally-vetted DET list.

Sleepio is a digital therapeutic (DTx), developed by Big Health, used for insomnia and insomnia symptoms. It is available in the United Kingdom through a regional or time-limited pilot commissioning arrangement, not (yet) an established national or ongoing regional/selective contract.

ieso Digital Health (Mindler) is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by ieso Digital Health (trading as Mindler), used for depression, anxiety and related common mental health conditions. It is reimbursed in the United Kingdom through regional or insurer-specific contracts rather than a nationwide scheme.

Lumi Nova is a digital therapeutic (DTx), developed by BFB Labs, used for mild-to-moderate anxiety, ages 7-12. It is available in the United Kingdom through a regional or time-limited pilot commissioning arrangement, not (yet) an established national or ongoing regional/selective contract.

Somzz is a digital therapeutic (DTx), developed by AIMMED (에임메드), used for chronic insomnia. CBT-i (cognitive behavioural therapy for insomnia) programme. It is available in South Korea on a self-pay basis -- a reimbursement-eligible pathway may exist, but the patient currently pays out of pocket rather than an insurer or employer.

SleepQ (formerly WELT-I) is a digital therapeutic (DTx), developed by WELT Corp (웰트) / Handok (한독, commercial partner), used for chronic insomnia. CBT-i programme. It is available in South Korea on a self-pay basis -- a reimbursement-eligible pathway may exist, but the patient currently pays out of pocket rather than an insurer or employer.

VIVID Brain is a digital therapeutic (DTx), developed by Nunaps (뉴냅스), used for hemianopia (visual field loss following brain lesion/stroke). Cognitive/visual-perceptual training. It is available in South Korea on a self-pay basis -- a reimbursement-eligible pathway may exist, but the patient currently pays out of pocket rather than an insurer or employer.

EasyBreath is a digital therapeutic (DTx), developed by Share&Service (쉐어앤서비스), used for COPD, asthma, lung-cancer-related. Respiratory rehabilitation. It is available in South Korea on a self-pay basis -- a reimbursement-eligible pathway may exist, but the patient currently pays out of pocket rather than an insurer or employer.

SoriCLEAR is a digital therapeutic (DTx), developed by NuLive (뉴라이브), used for tinnitus. It is available in South Korea on a self-pay basis -- a reimbursement-eligible pathway may exist, but the patient currently pays out of pocket rather than an insurer or employer.

CodeThera is a digital therapeutic (DTx), developed by EmocoG (이모코크), used for mild cognitive impairment (MCI). It is available in South Korea on a self-pay basis -- a reimbursement-eligible pathway may exist, but the patient currently pays out of pocket rather than an insurer or employer.

CureApp SC is a digital therapeutic (DTx), developed by CureApp, Inc., used for nicotine dependence / smoking cessation, used alongside varenicline. It is reimbursed nationally in Japan via an NHI Chuikyo (Central Social Insurance Medical Council) listing. Reimbursed since 1 Dec 2020 -- NHI reimbursement price: 2,540 points (~JPY25,400) per course of treatment.

CureApp HT is a digital therapeutic (DTx), developed by CureApp, Inc., used for hypertension, adjunct to lifestyle-modification therapy. It is reimbursed nationally in Japan via an NHI Chuikyo (Central Social Insurance Medical Council) listing. Reimbursed since 1 Sept 2022 -- NHI reimbursement price: JPY7,010.

CureApp AUD (marketed as HAUDY) is a digital therapeutic (DTx), developed by CureApp, Inc. (developer); Sawai Pharmaceutical (commercial distribution), used for alcohol use disorder / drinking-reduction treatment. It is reimbursed nationally in Japan via an NHI Chuikyo (Central Social Insurance Medical Council) listing. Reimbursed since 1 Sept 2025 -- NHI-listed; 3rd CureApp product to reach reimbursement, commercialised in partnership with Sawai Pharmaceutical as 'HAUDY'.

Medcle (formerly Med CBT-i) is a digital therapeutic (DTx), developed by SUSMED, Inc. (developer); Shionogi (commercialisation partner), used for insomnia disorder. 9-week CBT-I (cognitive behavioural therapy for insomnia) programme. It is reimbursed nationally in Japan via an NHI Chuikyo (Central Social Insurance Medical Council) listing. Approved for reimbursement 13 May 2026, effective 1 Jun 2026 -- NHI reimbursement price JPY24,100, plus guidance-management fee (B005-14: 90 points) and induction-phase add-on (50 points).

ENDEAVORRIDE is a digital therapeutic (DTx), developed by Shionogi & Co., Ltd. (Japan rights; underlying technology from Akili Interactive, USA), used for paediatric ADHD, ages 6-17, when environmental/psychosocial interventions are insufficient. It is reimbursed nationally in Japan via an NHI Chuikyo (Central Social Insurance Medical Council) listing. Approval 13 Feb 2025; reimbursement effective 5 Jun 2026 -- NHI reimbursement: material fee 1,450 points for the app + guidance-management fee (B005-14: 90 points) + induction-phase add-on (50 points); limited to 2 prescriptions per patient.

SleepioRx is a digital therapeutic (DTx), developed by Big Health, used for chronic insomnia. It is reimbursed nationally in the USA via Medicare's HCPCS G0552-G0554 digital mental health treatment codes. Reimbursed since 1 Jan 2025 -- Billed by the prescribing clinician: G0552 (device supply/onboarding) + G0553/G0554 (monthly treatment-management time, ~$20/20min).

Daylight (DaylightRx) is a digital therapeutic (DTx), developed by Big Health, used for generalised anxiety disorder. It is reimbursed nationally in the USA via Medicare's HCPCS G0552-G0554 digital mental health treatment codes. Reimbursed since 1 Jan 2025 -- Billed by the prescribing clinician: G0552 + G0553/G0554.

Rejoyn is a digital therapeutic (DTx), developed by Otsuka Precision Health / Click Therapeutics, used for major depressive disorder (adjunct, ages 22+). It is reimbursed nationally in the USA via Medicare's HCPCS G0552-G0554 digital mental health treatment codes. Medicare-billable since 1 Jan 2025; broader commercial-payer coverage NOT confirmed -- Billed by the prescribing clinician: G0552 + G0553/G0554; as of Apr 2025 no commercial insurer publicly confirmed on board -- still largely self-pay/discounted cash (~$50) or Medicare-billed only.

reSET is a digital therapeutic (DTx), developed by PursueCare (acquired Pear Therapeutics' reSET/reSET-O assets, 2023), used for substance use disorder. It is reimbursed nationally in the USA via Medicare's HCPCS G0552-G0554 digital mental health treatment codes. Reimbursed since 1 Jan 2025 (Medicare); commercial coverage via Cigna PDT policy -- Billed by the prescribing clinician: G0552 + G0553/G0554.

reSET-O is a digital therapeutic (DTx), developed by PursueCare (acquired Pear Therapeutics' reSET/reSET-O assets, 2023), used for opioid use disorder. It is reimbursed nationally in the USA via Medicare's HCPCS G0552-G0554 digital mental health treatment codes. Reimbursed since 1 Jan 2025 (Medicare); commercial coverage via Cigna PDT policy -- Billed by the prescribing clinician: G0552 + G0553/G0554.

Somryst is a digital therapeutic (DTx), developed by Nox Health (acquired the Somryst asset from Pear Therapeutics' bankruptcy estate), used for chronic insomnia. It is reimbursed nationally in the USA via Medicare's HCPCS G0552-G0554 digital mental health treatment codes. Reimbursed since 1 Jan 2025 (Medicare); added to Serve You Rx/OptumRx pharmacy-benefit formularies for select commercial/self-insured employer plans -- Billed by the prescribing clinician: G0552 + G0553/G0554; formulary listing separately covers the device cost for enrolled plan members.

MamaLift Plus is a digital therapeutic (DTx), developed by Curio Digital Therapeutics, used for postpartum / maternal mental health. It is reimbursed nationally in the USA via Medicare's HCPCS G0552-G0554 digital mental health treatment codes. Reimbursed since 1 Jan 2025 -- Billed by the prescribing clinician: G0552 + G0553/G0554.

Xinjing Technology VR Insomnia-Disorder Therapy Software (心景科技) is a connected medical device (with companion software), developed by Xinjing Technology (心景科技), used for insomnia disorder. VR-based cognitive-behavioural/relaxation therapy. It is billable in China (Hainan province) under a provincial fee-schedule, not yet nationwide health insurance.

Hainan Class II DTx #4 -- Exercise/Cardiopulmonary Rehab Training Software (运动康复训练软件) is a digital therapeutic (DTx), used for cardiopulmonary rehabilitation. Structured exercise-training programme to aid clinicians guiding patients through cardiopulmonary function rehab. It is billable in China (Hainan province) under a provincial fee-schedule, not yet nationwide health insurance.

Hainan Class II DTx #5 -- Pulmonary Function Rehab Training Software (肺功能康复训练软件) is a digital therapeutic (DTx), used for pulmonary (lung) function rehabilitation. Structured training programme to aid clinicians guiding patients through pulmonary rehab. It is billable in China (Hainan province) under a provincial fee-schedule, not yet nationwide health insurance.

Hainan Class II DTx #6 -- Cardiopulmonary Walking-Test Data Analysis Software (心肺步行试验数据分析软件) is a digital therapeutic (DTx), used for exercise cardiopulmonary function assessment. Analyses walking-test data to assist medical staff (no automated diagnosis). It is billable in China (Hainan province) under a provincial fee-schedule, not yet nationwide health insurance.

Hainan Class II DTx #7 -- Cognitive Impairment Assessment & Training Software (认知功能障碍评估与训练软件) is a digital therapeutic (DTx), used for mild cognitive impairment. Adjunct assessment and training aid. It is billable in China (Hainan province) under a provincial fee-schedule, not yet nationwide health insurance.

6 additional Hainan Class II-approved DTx products (#1-3 pre-Feb-2024, #8-11 during 2025 -- not individually named or dated in this pass) is a digital therapeutic (DTx), used for aggregate reference row. Hainan's provincial regulator had approved 11 DTx products under its Class II fast-track as of its own Nov 2025 press release (up from the 10-product Aug 2025 trade-press figure used elsewhere in this tab); this row stands in for the 6 beyond the 5 named/dated above (Xinjing plus approvals #4-7), spanning chronic-disease management, psychiatric/cognitive, ophthalmology, oncology and...

Sword Thrive is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by Sword Health, Inc., used for musculoskeletal pain. Back, joint, neck, shoulder and repetitive-strain conditions. It is offered in the USA as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

Sword Mind is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by Sword Health, Inc., used for anxiety, depression and other common mental-health conditions. It is offered in the USA as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

Sword Bloom is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by Sword Health, Inc., used for women's health across every life stage. Incl. pregnancy, postpartum and menopause-related conditions. It is offered in the USA as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

Sword Pulse is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by Sword Health, Inc., used for cardiometabolic health. E.g. hypertension, high cholesterol, weight-related risk. It is offered in the USA as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

Omada Cardiometabolic Suite (Prevention, Diabetes, Hypertension, GLP-1 support) is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by Omada Health, Inc., used for prediabetes, type 1 & 2 diabetes, hypertension, and support for members on GLP-1/anti-obesity medications. It is offered in the USA as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

Omada for Joint & Muscle Health is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by Omada Health, Inc., used for musculoskeletal pain. Joint and muscle conditions. It is offered in the USA as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

Hinge Health (core MSK programme) is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by Hinge Health, Inc., used for musculoskeletal pain. Back, joint, knee, shoulder and general chronic pain. It is offered in the USA as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

Hinge Health Global -- Germany is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by Hinge Health, Inc., used for musculoskeletal pain (same core programme as the US employer offering). It is offered in Germany as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

Hinge Health Global -- United Kingdom is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by Hinge Health, Inc., used for musculoskeletal pain (same core programme as the US employer offering). It is offered in the United Kingdom as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

Hinge Health Women's Pelvic Health is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by Hinge Health, Inc., used for pelvic-floor disorders. Prolapse, diastasis recti (abdominal separation), bladder/bowel problems, chronic pelvic pain; across pregnancy, postpartum and menopause. It is offered in the USA as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

HingeSelect is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by Hinge Health, Inc., used for musculoskeletal conditions requiring in-person/specialist follow-up (surgical candidates, high-risk members). It is offered in the USA as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

Hinge Health Migraine Care Program is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by Hinge Health, Inc., used for migraine. It is offered in the USA as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

teamfit is a digital prevention programme, developed by Teamfit GmbH, used for general workplace movement, motivation and vital-sign wellness. Not indication-specific. It is offered in Germany as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

nilo is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by Likenilo GmbH (trading as nilo; formerly Nilo Health, merged with Likeminded Feb 2025), used for mental health. Stress, burnout prevention, and general psychological wellbeing support for employees and managers. It is offered in Germany as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

Deep Care (Isa) is a digital prevention programme, developed by Deep Care GmbH, used for workplace ergonomics, posture, stress and indoor air-quality monitoring. Not indication-specific. It is offered in Germany as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

onyo is a digital prevention programme, developed by onyo GmbH, used for home-office/remote-work ergonomics and statutory workplace risk assessment. Not indication-specific. It is offered in Germany as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

Prevenio (R) is a digital prevention programme, developed by TransGate GmbH, used for statutory occupational-medical fitness/eligibility examinations and preventive check-ups. Administrative/compliance tool, not indication-specific. It is offered in Germany as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

MOVEVO App is a digital prevention programme, developed by Movevo Technologies GmbH, used for general workplace movement and physical-activity motivation. Not indication-specific. It is offered in Austria as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

Humanoo is a digital prevention programme, developed by Humanoo GmbH (trading as eTherapists GmbH), used for general workplace fitness, physiotherapy, yoga, meditation, nutrition and sleep. Not indication-specific. It is offered in Germany as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

Wellnow -- Smart Corporate Health is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by Wellnow Health GmbH, used for general workplace physical and mental wellbeing. On-site massage, physiotherapy, yoga, back-training, mindfulness -- not indication-specific. It is offered in Germany as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

EGYM Wellpass (formerly qualitrain) is a digital prevention programme, developed by EGYM Wellpass GmbH (part of EGYM GmbH), used for general fitness and wellness access. Not indication-specific. It is offered in Germany as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

Hansefit is a digital prevention programme, developed by Hansefit GmbH (part of Epassi Group), used for general fitness and wellness access, plus individually rewarded health activities. Not indication-specific. It is offered in Germany as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

Healthclapp is a digital prevention programme, developed by Healthclapp (Schuljahr & Putz), used for general workplace physical activity motivation. Not indication-specific. It is offered in Germany as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

YuMuuv is a digital prevention programme, developed by YuMuuv OU, used for general team fitness and step/activity challenges. Not indication-specific. It is offered in Estonia as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

IncentFit is a digital prevention programme, developed by IncentFit, Inc., used for general fitness, wellness benefits and reimbursements. Not indication-specific. It is offered in the USA as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

Personify Health is a digital prevention programme, developed by Personify Health, Inc. (formerly Virgin Pulse + HealthComp), used for general employee wellbeing, health-plan navigation and personalised health journeys. Not indication-specific. It is offered in the USA as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

Headspace for Work / Headspace Care (incl. Ginger) is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by Headspace Health, Inc. (Headspace + Ginger), used for mindfulness, stress, anxiety, depression and general mental-health support. Not indication-specific. It is offered in the USA as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

Limeade is a digital prevention programme, developed by Limeade, Inc., used for general employee wellbeing and organisational-listening/survey tools. Not indication-specific. It is offered in the USA as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

Grokker is a digital prevention programme, developed by Grokker, Inc., used for general physical, emotional and financial wellbeing via video content. Not indication-specific. It is offered in the USA as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

Vantage Fit is a digital prevention programme, developed by Vantage Circle (Intellicorp Consulting Pvt. Ltd.), used for general fitness tracking, mood, heart-rate and workout gamification. Not indication-specific. It is offered in the USA as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

GoJoe is a digital prevention programme, developed by GoJoe Ltd., used for general social/team fitness challenges and physical, mental and social wellbeing. Not indication-specific. It is offered in the United Kingdom as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

CoreHealth (now CoreHealth by Carebook) is a digital prevention programme, developed by CoreHealth Technologies Inc., used for general corporate wellness programme administration. Flexible/white-label, not indication-specific. It is offered in Canada as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

WellSteps is a digital prevention programme, developed by WellSteps, LLC, used for general wellness behavior change across six health pillars. Not indication-specific. It is offered in the USA as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

Gymlib is a digital prevention programme, developed by Gymlib SAS, used for general fitness and wellness facility access. Not indication-specific. It is offered in France as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

Champion Health is a digital prevention programme, developed by Champion Health Ltd., used for mental health and musculoskeletal risk, plus physical and financial wellbeing. Not indication-specific. It is offered in the United Kingdom as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

Wellhub (formerly Gympass) is a digital prevention programme, developed by Wellhub, Inc. (formerly Gympass), used for general fitness, mental wellness, nutrition and sleep. Not indication-specific. It is offered in the USA as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

Calorymama Plus (Karo Mama Purasu) is a digital prevention programme, developed by Wellmira Inc. / Link and Communication Co., Ltd., used for general nutrition, exercise and sleep health management via AI photo-based food logging. Not indication-specific. It is offered in Japan as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

Ahead Health is a digital prevention programme, developed by Ahead Health AG, used for early detection of cancer, cardiovascular disease and other conditions via preventive full-body screening. Not indication-specific. It is offered in Switzerland as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

Unmind is a digital prevention programme, developed by Unmind Ltd., used for workplace mental health. Stress, anxiety, depression, sleep and general psychological wellbeing -- not indication-specific. It is offered in the United Kingdom as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

Peppy is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by Peppy Health Ltd., used for menopause, fertility, and men's health (including prostate and mental health). Specialist life-stage health support for employees. It is offered in the United Kingdom as an employer-sponsored corporate-health benefit, paid for by the employer or health plan rather than a statutory or private insurer.

Patient Journey App (platform) is a hospital patient-information and care-pathway companion app, developed by Patient Journey App, used for perioperative and general hospital-stay information across surgical and non-surgical care pathways, department- and procedure-configurable per hospital. It is provided free in Germany by the treating hospital or device manufacturer as part of the care episode itself -- not billed to any insurer, employer or the patient.

Curalie App is a blended-care digital health programme, combining software with ongoing clinician or coach involvement, developed by Curalie GmbH, used for multi-programme digital health companion: Surgery Companion (perioperative), Diabetes Guide (type 2 diabetes), Heart Guide (atrial fibrillation & heart failure), plus general symptom-check and telemedicine ('Telearzt') video consultations. It is available in Germany on a self-pay basis -- a reimbursement-eligible pathway may exist, but the patient currently pays out of pocket rather than an insurer or employer.

ForPatientApp (B. Braun) is a remote-monitoring / digital health platform, developed by B. Braun Melsungen AG, used for perioperative guidance for hip and knee replacement, spine surgery, hernia surgery and colorectal surgery. Pre-op preparation, post-op recovery information, an assignable exercise programme (ForPatientApp Move), and PROM/PREM (patient-reported outcome/experience measure) data collection. It is provided free in Germany by the treating hospital or device manufacturer as part of the care episode itself -- not billed to any insurer, employer or the patient.

MeineSana (Sana Kliniken) is a hospital patient-information and care-pathway companion app, developed by Sana Kliniken AG, used for perioperative and general-treatment patient information across the Sana Kliniken hospital network. Live variants include hip/knee surgery preparation (Sana Kliniken Sommerfeld), obesity-centre patients (Karl-Olga Hospital Stuttgart), and general hospital-stay guidance (Sana Klinikum Munich, Rummelsberg, Baumann Klinik). It is provided free in Germany by the treating hospital or device manufacturer as part of the care episode itself -- not billed to any...

CorinRPM (Corin -- Connected Orthopaedic Insight) is a remote-monitoring / digital health platform, developed by Corin Group (Corin Limited), used for hip and knee replacement (joint arthroplasty) perioperative patient engagement, PROMs collection, and progressive post-op exercise videos, feeding the surgeon-facing CorinConnect analytics platform. It is provided free in the United Kingdom by the treating hospital or device manufacturer as part of the care episode itself -- not billed to any insurer, employer or the patient.

NielsApp (Mein Kunstgelenk) is a hospital patient-information and care-pathway companion app, developed by Niels-Stensen-Kliniken GmbH, used for perioperative patient information for hip and knee joint replacement surgery at Niels-Stensen-Kliniken. It is provided free in Germany by the treating hospital or device manufacturer as part of the care episode itself -- not billed to any insurer, employer or the patient.

endogApp is a hospital patient-information and care-pathway companion app, developed by endogap Klinik für Gelenkersatz (Klinikum Garmisch-Partenkirchen GmbH), used for perioperative patient information and individual treatment timeline for hip and knee joint replacement surgery at endogap Klinik für Gelenkersatz (Klinikum Garmisch-Partenkirchen). It is provided free in Germany by the treating hospital or device manufacturer as part of the care episode itself -- not billed to any insurer, employer or the patient.

mymobility (Zimmer Biomet) is a remote-monitoring / digital health platform, developed by Zimmer Biomet Holdings, Inc., used for hip and knee replacement (joint arthroplasty) perioperative care management. Pre/post-op education, PROMs, and passive step-count/mobility tracking via a connected Apple Watch, feeding a surgeon-facing dashboard. It is reimbursed nationally in the USA via Medicare's Remote Therapeutic Monitoring CPT codes (98975-98981). Live -- widely deployed across US orthopaedic practices using Zimmer Biomet hip/knee implants -- App is free for the patient; the enrolling...

viatolea is a digital therapeutic (DTx), developed by PYRA MEDI GmbH (Nuremberg, Germany, founded 2024), used for food intolerances (fructose, sorbitol, lactose, wheat sensitivity). A digital nutrition journal plus an algorithm identifies likely intolerances from logged meals/symptoms and guides users through guideline-compliant dietary changes over a 10-week programme. It is reimbursed in Germany through regional or insurer-specific contracts rather than a nationwide scheme.

10-week programme

brite (XO Life, formerly ImpactMonitor) is a manufacturer-sponsored digital therapy-support platform, developed by XO Life GmbH (Munich, Germany), used for asthma and COPD digital therapy support funded via a biosyn partnership, alongside a broader medication-adherence and side-effect-tracking service spanning 30+ condition areas with various pharmaceutical partners. Unlike this dataset's other entries, funding comes from the drug/device manufacturer paying XO Life directly, rather than a statutory health insurer or employer.

TheraKey (Berlin-Chemie) is a manufacturer-sponsored patient-education and therapy-support platform, developed and funded by Berlin-Chemie AG (Berlin, Germany; part of the Menarini Group), launched in 2012, used for patient education and therapy support across 8 chronic conditions including Type 1/Type 2 diabetes, hypertension, COPD, asthma, angina pectoris, dyslipidemia, gout and premature ejaculation. Unlike this dataset's other entries, funding comes from the drug manufacturer directly, rather than a statutory health insurer or employer.

Hyperhero (brainjo) is a digital therapeutic (DTx), developed by brainjo (Regensburg, Germany, founded 2022), used for ADHD (children, ages 8-13). A VR-based therapy delivered across 24 sessions in 5 modules over roughly 3 months (~40 minutes per session), developed in partnership with MEDICE and backed by EUR2M HTGF seed funding (Apr 2026). It is available in Germany on a self-pay basis while the company pursues DiGA listing, targeted for 2028.

3 months (24 sessions across 5 modules, ~40 min/session)

EndeavorRx is a digital therapeutic (DTx), developed by Akili Interactive Labs, Inc. (Boston, MA), used for ADHD -- inattention in children (ages 8-12). Delivered as a video-game-based intervention played roughly 25 minutes a day, 5 days a week, for a minimum of 4 weeks, it received FDA De Novo clearance in 2020 as the first prescription treatment delivered through a video game. It is selectively reimbursed in the US: some commercial payers and state Medicaid plans (e.g. Highmark BCBS, Molina Medicaid Ohio) cover it under outcome-based contracts, while others still classify it as investigational; a self-pay, non-prescription OTC version is also available independent of insurance.

4 weeks minimum (25 min/day, 5 days/week)

CardioSignal is a CE Class IIa-certified digital health monitoring app, developed by Precordior Oy (Turku, Finland), used for atrial fibrillation detection via a 60-second smartphone-based chest measurement using the phone's accelerometer and gyroscope. It is sold self-pay direct-to-consumer in 15+ countries. Precordior is separately one of 10 companies selected for Finland's DigiFinland pilot (Oct 2025), a government evaluation programme testing how digital therapies should integrate into the healthcare system -- the pilot itself carries no reimbursement mechanism yet.

60-second measurement

Sooma tDCS is an EU MDR-certified transcranial direct current stimulation (tDCS) device, developed by Sooma Oy (Helsinki, Finland), used for depression and chronic pain via a non-invasive brain-stimulation headset worn for 30-minute sessions, 5 days a week, for a minimum of 4 weeks. It is sold direct-to-patient (self-pay) in Finland and Germany, ordered online with no referral required. Sooma is separately one of 10 companies selected for Finland's DigiFinland pilot (Oct 2025), a government evaluation programme -- the pilot itself carries no reimbursement mechanism yet.

4 weeks minimum (30 min/session, 5 days/week)

Freespira is an FDA-cleared digital therapeutic, developed by Freespira, Inc. (Menlo Park, CA), used for panic attacks (panic disorder) and PTSD. It pairs a home-use breathing-sensor device with a 28-day program of twice-daily sessions to normalize respiration patterns linked to panic and hyperarousal symptoms. Cleared by the FDA since 2018 for adults, with a 2025 expansion to adolescents (13-17), it is reimbursed by several named commercial health plans and is eligible for Medicare billing under the DMHT G-codes (G0552-G0554), the same reimbursement family used by Akili, Big Health and Otsuka's prescription digital therapeutics.

28-day program (2 sessions/day)

Luminopia is an FDA-cleared digital therapeutic, developed by Luminopia, Inc. (Boston, MA), used to treat amblyopia ("lazy eye") in children. Delivered through a VR headset streaming modified television and video content that trains the amblyopic eye during normal at-home viewing, it received FDA De Novo clearance in Oct 2021 for ages 4-7, expanded to ages 8-12 in Apr 2025. It is actively covered by named commercial payers including Anthem Blue Cross Blue Shield and CareFirst BlueCross BlueShield.

Prescribed course, typically several months

InTandem is an FDA-cleared, home-use digital therapeutic device, developed by MedRhythms, Inc. (Portland, ME), used for gait and mobility impairment after chronic stroke. It combines wearable movement sensors with auditory rhythmic cueing to guide walking rehabilitation. Following a 2020 FDA Breakthrough Device designation and 2023 Class II clearance, CMS finalized a dedicated Medicare Durable Medical Equipment billing code (HCPCS E3200) in Jan 2025, giving an estimated 15 million Medicare beneficiaries and roughly 800,000 chronic-stroke patients a reimbursement pathway to access it.

Ongoing home-use therapy

RelieVRx is an FDA-authorized virtual-reality digital therapeutic, developed by AppliedVR, Inc. (Los Angeles, CA), used for chronic lower back pain. It delivers an 8-week program of cognitive-behavioral and pain-education skills through an immersive VR headset. Authorized by the FDA via the De Novo pathway in Nov 2021, it became the first VR therapeutic to receive its own Medicare billing code when CMS assigned HCPCS Level II code E1905 (effective Apr 2023), classified as Durable Medical Equipment. CMS has not yet finalized the payment rate for this code, so real-world coverage remains uneven and payer-dependent in the meantime.

8-week program (skills-based sessions)

EndeavorOTC is an FDA-cleared, over-the-counter digital therapeutic, developed by Akili Interactive Labs, Inc. (Boston, MA), used for ADHD-related inattention in adults. It uses the same game-based mechanism as Akili's prescription product EndeavorRx (tracked separately for children ages 8-12), cleared in Jun 2024 as a distinct, adult-facing, non-prescription SKU. It is sold direct-to-consumer through app stores on a self-pay basis, independent of Medicare DMHT billing or commercial-payer contracts.

4 weeks minimum (25 min/day, 5 days/week)

BlueStar is an FDA-cleared digital therapeutic, developed by Welldoc, Inc. (Columbia, MD), used for type 1 and type 2 diabetes management. One of the earliest FDA-cleared DTx products (original clearance 2013, with 10+ subsequent clearances), it combines a patient-facing coaching app with connected glucose-meter/CGM data for the prescribing clinician. It is reimbursed today primarily through Medicare and commercial Remote Patient Monitoring billing (CPT 99453/99454/99457), billed by the treating clinician -- a different code family from the Medicare DMHT G-codes used by behavioral-health digital therapeutics -- and is also distributed via employer and health-plan contracts.

Ongoing chronic-care management

Luscii is a remote patient monitoring platform, developed by Luscii Healthtech B.V. (Amsterdam, Netherlands; an OMRON Healthcare company since its April 2024 acquisition), used for chronic-disease monitoring including heart failure, COPD and hypertension. Founded in 2013 by Ronald Scheffer, Joris Janssen and Daan Dohmen, it combines a patient-facing app with connected monitoring devices and clinician dashboards. The Netherlands has no DiGA-style dedicated digital-therapeutics reimbursement code; instead, Luscii is billed under the general Zvw basic health insurance rules whenever the clinical activity it supports is already covered. Despite the lack of a dedicated pathway, adoption is substantial: reimbursed by an estimated 94% of Dutch insurers and used across the majority of Dutch hospitals.

Ongoing chronic-care management

Minddistrict is a blended e-mental-health platform, developed by Minddistrict B.V. (Amsterdam, Netherlands; founded 2008), used by Dutch GGZ (mental health and addiction care) providers to deliver online modules, care plans and questionnaires alongside standard therapy for conditions including depression, anxiety and addiction. Described as the market leader in e-mental health in the Netherlands, it has no dedicated digital-therapeutics reimbursement code of its own -- it is billed as part of the standard GGZ treatment course it supports, reimbursed under the same general Zvw basic health insurance rules as that underlying care.

Ongoing -- part of a standard GGZ treatment course

MoovCare Poumon is a digital therapeutic, developed by Sivan France, used for post-treatment follow-up for lung cancer patients -- early detection of relapse and complications via a weekly web-based patient symptom questionnaire, analysed by an algorithm that alerts the care team. Listed on France's LPP (reimbursable products list) since a 2019 CNEDiMTS opinion (Service Rendu Suffisant, ASA level III/moderate).

Cordiva is a digital therapeutic, developed by CDM e-Health, used for remote home monitoring of chronic heart failure patients -- symptom questionnaire plus connected weighing scale, with alerts to the care team. A 2016 CNEDiMTS opinion did not recommend Cordiva for standard LPP listing, citing insufficient/non-transposable evidence of therapeutic benefit.

Diabeo is a digital therapeutic, developed by Voluntis, used for insulin-dose titration support for insulin-treated diabetes patients -- mobile app calculates bolus/basal dose recommendations from blood-glucose and carbohydrate data, with an optional clinician web portal for telemonitoring. Reimbursed on France's LPP since a September 2016 HAS opinion -- reported as the first digital health app reimbursed by French statutory health insurance (Assurance Maladie).

Zio XT is a digital therapeutic, developed by iRhythm Technologies, Inc., used for ambulatory ECG monitoring (>24 hours) for people with suspected cardiac arrhythmias -- wearable single-lead ECG patch, algorithmic analysis, and clinician report. NICE Medical Technologies Guidance MTG52 recommends Zio XT as an option for ambulatory ECG monitoring beyond 24 hours, replacing standard Holter monitors in eligible NHS pathways.

myCOPD is a digital therapeutic, developed by My mHealth Limited, used for cOPD self-management -- digital pulmonary rehabilitation, symptom tracking, inhaler-technique training, education and medication support, with clinician communication. Formally recognised in two NICE Early Value Assessments (HTE18 for pulmonary rehabilitation, HTE19 for broader self-management), giving conditional NHS commissioning approval until December 2027 while further outcomes evidence is generated.

isi PMS App is a digital therapeutic (DTx), developed by Endo Health GmbH, used for premenstrual syndrome (PMS). It is reimbursed nationally in Germany via the DiGA §139e SGB V pathway. SHI-reimbursed, DiGA (provisional); manufacturer price EUR598.95/90-day Rx (diga.bfarm.de).

detoxi Health App is a digital prevention programme, developed by detoxi Health GmbH, used for digital stress management. App-blocking, focus sessions and 300+ "life hacks" to reduce screen time and digital stress. It is reimbursed nationally in Germany via the §20 SGB V Leitfaden Prävention pathway (ZPP-certified). SHI-reimbursed up to 100% of EUR99.99 course fee after completing 40 missions over 9 weeks and submitting a participation certificate; ZPP-certified under Sec.20 Abs.1 SGB V, course ID KU-ST-4JDL2F.

9 weeks

CyberHealth is a digital prevention programme, developed by CyberHealth, used for platform of 11 certified 8-week online prevention courses (weight loss, back coaching, yoga, pilates, diabetes prevention, PMR relaxation, smoking cessation, nutrition). Video modules plus downloadable materials and a short weekly questionnaire, on-demand via app or browser. It is reimbursed nationally in Germany via the §20 SGB V Leitfaden Prävention pathway (ZPP-certified). Certified Sec.20 SGB V online courses meeting the GKV-Spitzenverband's Leitfaden Praevention requirements; most statutory insurers...

8 weeks

Prevencer is a digital prevention programme, developed by Prevencer, used for krafttraining ohne Geraete. Equipment-free strength-training online prevention course. It is reimbursed nationally in Germany via the §20 SGB V Leitfaden Prävention pathway (ZPP-certified). ZPP-zertifizierter Online-Praeventionskurs nach Sec.20 SGB V; bis zu 100% Kostenerstattung durch die gesetzliche Krankenkasse.

Gymondo Praeventionskurse is a digital prevention programme, developed by Gymondo GmbH, used for rueckenfit, Laufen and Funktionelle Ganzkoerperkraeftigung. Movement-based online prevention courses guided by physiotherapists/Reha-Trainer. It is reimbursed nationally in Germany via the §20 SGB V Leitfaden Prävention pathway (ZPP-certified). Offiziell nach Sec.20 Abs.1 SGB V durch die ZPP zertifiziert; bis zu 100% Kostenerstattung durch die gesetzliche Krankenkasse; EUR99 je Kurs.

10 weeks

taozen is a digital prevention programme, developed by Tao Zen, used for tai-Chi- and Qigong-based online movement courses (fernoestliche Bewegungslehren) for stress reduction. It is reimbursed nationally in Germany via the §20 SGB V Leitfaden Prävention pathway (ZPP-certified). Zertifiziert nach Sec.20 SGB V (ZPP); Erstattung bis zu 100% durch die gesetzliche Krankenkasse, zweimal jaehrlich bezuschusst.

MANN is(s)t smart is a digital prevention programme, developed by Mann-isst-smart / ESG, used for 10-week digital nutrition course for men, covering diet basics, heart health, metabolism and everyday-compatible eating habits. It is reimbursed nationally in Germany via the §20 SGB V Leitfaden Prävention pathway (ZPP-certified). Zertifiziertes Praeventionsangebot nach Sec.20 SGB V; 80-100% Erstattung durch die gesetzliche Krankenkasse; EUR89.

10 weeks

myWEIGHTcoach / myHEALTHcoach is a digital prevention programme, developed by ESG, used for 8-week digital nutrition and weight-management courses (myWEIGHTcoach for weight loss, myHEALTHcoach for general healthy eating) offered through multiple statutory insurers. It is reimbursed nationally in Germany via the §20 SGB V Leitfaden Prävention pathway (ZPP-certified). ZPP-zertifiziert nach Sec.20 SGB V; EUR89, 71-89% Erstattung je nach Krankenkasse; gelistet u.a. bei KKH, Novitas-BKK, meine krankenkasse.

8 weeks

bauchgefuehl is a digital prevention programme, developed by bauchgefuehl, used for online course on gut health and digestion (Darmgesundheit). It is reimbursed nationally in Germany via the §20 SGB V Leitfaden Prävention pathway (ZPP-certified). Zertifiziert nach Sec.20 SGB V; bis zu 100% Zuschuss der gesetzlichen Krankenkasse.

Schlank ohne Diaet is a digital prevention programme, developed by Fitnessdoc.net, used for certified online course for sustainable weight loss without dieting. It is reimbursed nationally in Germany via the §20 SGB V Leitfaden Prävention pathway (ZPP-certified). Zertifizierter Praeventionskurs nach Sec.20 SGB V; Kosten koennen von der gesetzlichen Krankenkasse uebernommen werden.

Gesundheitskurs.de (Plattform) is a digital prevention programme, developed by Gesundheitskurs.de, used for platform hosting multiple ZPP-certified online prevention courses across movement, nutrition and stress/resilience, recognised by German statutory insurers. It is reimbursed nationally in Germany via the §20 SGB V Leitfaden Prävention pathway (ZPP-certified). Nr.1-Plattform fuer zertifizierte Praeventionskurse; alle gelisteten Kurse nach Sec.20 SGB V zertifiziert; bis zu 100% Kostenerstattung.

mom2be is a digital prevention programme, developed by mom2be, used for online courses covering pregnancy and the postpartum period (Beckenbodentraining, Pilates, Yoga). It is reimbursed nationally in Germany via the §20 SGB V Leitfaden Prävention pathway (ZPP-certified). Von den gesetzlichen Krankenkassen gefoerderte, zertifizierte Online-Kurse nach Sec.20 SGB V.

FIT UND GESUND COACH is a digital prevention programme, developed by FIT UND GESUND COACH, used for starke Beine (Kniekrafttraining), Vom Walken zum Laufen and Rueckenfit. Movement-focused online prevention courses. It is reimbursed nationally in Germany via the §20 SGB V Leitfaden Prävention pathway (ZPP-certified). ZPP-zertifiziert nach Sec.20 SGB V; EUR119, bis zu 100% Erstattung durch die gesetzliche Krankenkasse.

Nacken-Athlet / MOBIFIT / Stickletics is a digital prevention programme, developed by Ramin Waraghai, used for neck/shoulder strength (Nacken-Athlet), mobility (MOBIFIT) and pole training (Stickletics). Movement-based online prevention courses by DSHS-Koeln-credentialed trainer Ramin Waraghai, hosted on gesundheitskurs.de. It is reimbursed nationally in Germany via the §20 SGB V Leitfaden Prävention pathway (ZPP-certified). ZPP-zertifiziert nach Sec.20 SGB V; EUR119, bis zu 100% Erstattung durch die gesetzliche Krankenkasse.

Sanum Entspannungskurs is a digital prevention programme, developed by Sanum, used for online audio-guided relaxation and stress-management course, 8 sessions of 45 minutes each. It is reimbursed nationally in Germany via the §20 SGB V Leitfaden Prävention pathway (ZPP-certified). Zertifizierter Praeventionskurs (ZPP), entspricht dem Leitfaden Praevention (Sec.20 Abs.1 SGB V); wird von allen gesetzlichen Krankenkassen erstattet; EUR99.

8 x 45 min

reset U is a digital prevention programme, developed by reset U, used for online courses for burnout prevention and depression prevention. It is reimbursed nationally in Germany via the §20 SGB V Leitfaden Prävention pathway (ZPP-certified). Zertifiziert nach Sec.20 SGB V (ZPP); EUR99, 79-99% Erstattung durch die gesetzliche Krankenkasse.